These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations.
    Author: Han SY, Lee JR, Kwon YK, Jo MJ, Park SJ, Kim SC, Lee HS, Ku SK.
    Journal: J Ethnopharmacol; 2007 Dec 03; 114(3):400-5. PubMed ID: 17905549.
    Abstract:
    AIM OF THE STUDY: The anti-osteoporotic effect of heated powder of Ostreae Testa (hPOT), a powder of oyster shell-Ostrea gigas Thumb (Ostrediae) was observed in vitro and in vivo. MATERIALS AND METHODS: The effects on proliferation and alkaline phosphatase activity of primary osteoblasts, bone nodule formation, pit formation of osteoclasts and osteoclastogenesis were observed in vitro, and to observe the in vivo efficacy hPOT was orally administered once a day for 28 days to bilateral ovariectomy-induced osteoporosis mice at 125, 250 and 500mg/kg (of body weight). RESULTS: Although hPOT did not influence the pit formation and the number of multinucleated osteoclast-like cells, osteoclastogenesis, it enhanced the proliferation of primary osteoblasts, differentiation (ALP activity) and bone nodule formation of osteoblast in vitro. The estrogen-deficient osteoporotic changes were dramatically prevented by hPOT treatment except for osteoclasts/bone perimeter. CONCLUSIONS: In conclusion, hPOT prevents OVX-induced osteoporosis through osteoblasts activation effects.
    [Abstract] [Full Text] [Related] [New Search]